Julie Randolph-Habecker

Title: Julie Randolph-Habecker: Innovator in Anti-ROR1 Antibodies

Introduction

Julie Randolph-Habecker is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-ROR1 antibodies. Her work has implications for diagnostic methods and treatment options for various diseases.

Latest Patents

Julie Randolph-Habecker holds 2 patents. Her latest patents focus on anti-ROR1 binding proteins, which include those that bind to a ROR1 protein or a portion thereof, such as the intracellular C terminal portion. These binding proteins are utilized in immunohistochemical and diagnostic methods. Additionally, related kits and methods for using these binding proteins are provided, along with treatment methods for subjects with diseases or conditions that are candidates for such treatments.

Career Highlights

Throughout her career, Julie has worked with esteemed organizations such as the Fred Hutchinson Cancer Center and the Fred Hutchinson Cancer Research Center. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Julie has collaborated with notable colleagues, including Ashwini Balakrishnan and Benjamin G Hoffstrom. These partnerships have further enriched her research and innovation in the field.

Conclusion

Julie Randolph-Habecker is a distinguished inventor whose work on anti-ROR1 antibodies has the potential to impact diagnostic and therapeutic approaches in medicine. Her contributions continue to shape the landscape of biotechnology and innovation.